Verfügbarkeit: Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis

Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis:

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Do, Nhu-Nguyen (VerfasserIn)
Format:	Abschlussarbeit Buch
Sprache:	English
Veröffentlicht:	Köln 2017
Schlagworte:	Hochschulschrift
Online-Zugang:	Inhaltsverzeichnis Inhaltsverzeichnis
Beschreibung:	91 Seiten Illustrationen 21 cm

Internformat

MARC


LEADER	00000nam a2200000 c 4500
001	BV044465056
003	DE-604
005	00000000000000.0
007	t
008	170829s2017 gw a\|\|\| m\|\|\| 00\|\|\| eng d
015			\|a 17,H06 \|2 dnb
016	7		\|a 1131738160 \|2 DE-101
035			\|a (OCoLC)990781560
035			\|a (DE-599)DNB1131738160
040			\|a DE-604 \|b ger \|e rda
041	0		\|a eng
044			\|a gw \|c XA-DE
049			\|a DE-83 \|a DE-355
084			\|a 610 \|2 sdnb
100	1		\|a Do, Nhu-Nguyen \|e Verfasser \|0 (DE-588)1125143614 \|4 aut
245	1	0	\|a Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis \|c vorgelegt von Nhu-Nguyen Do
264		1	\|a Köln \|c 2017
300			\|a 91 Seiten \|b Illustrationen \|c 21 cm
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
502			\|b Dissertation \|c Universität zu Köln \|d 2017
655		7	\|0 (DE-588)4113937-9 \|a Hochschulschrift \|2 gnd-content
856	4	2	\|m B:DE-101 \|q application/pdf \|u http://d-nb.info/1131738160/04 \|3 Inhaltsverzeichnis
856	4	2	\|m DNB Datenaustausch \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029865631&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
999			\|a oai:aleph.bib-bvb.de:BVB01-029865631

Datensatz im Suchindex

_version_	1804177792151060483
adam_text	TABLE OF CONTENT ZUSAMMENFASSUNG SUMMARY TABLE OF FIGURES TABLE OF TABLES 1 INTRODUCTION.................................................................................................................. -1 - 1.1 SKIN ARCHITECTURE AND FUNCTION ............................................................................. -1 - 1.1.1 EXTRACELLULAR MATRIX.......................................................................................- 2 - 1.2 SKIN FIBROSIS........................................................................................................... - 5 - 1.2.1 CUTANEOUS WOUND HEALING IN PHYSIOLOGY..................................................- 5 - 1.2.2 IMPAIRED WOUND HEALING AND PATHOLOGICAL FIBROTIC RESPONSES .............. - 7 - 1.2.3 MOUSE MODEL OF BLEOMYCIN-INDUCED SKIN FIBROSIS ................................... - 8 - 1.2.4 THE ROLE OF MACROPHAGES IN SKIN REPAIR AND FIBROSIS ............................. - 9 - 1.3 MACROPHAGES.......................................................................................................-10- 1.3.1 MACROPHAGE ORIGIN AND IDENTIFICATION......................................................-1 0 - 1.3.2 MACROPHAGE FUNCTION .................................................................................. -11- 1.3.3 MACROPHAGE ACTIVATION AND NOMENCLATURE ............................................ -1 2 - 1.3.4 TOLL-LIKE RECEPTOR 4 SIGNALING-MEDIATED INFLAMMATORY RESPONSE ........... -1 3 - 1.4 CYTOKINES, GROWTH FACTORS AND THEIR SIGNALING PATHWAYS ............................ -1 4 - 1.4.1 P38A M ARK................................................................................................. -14- 1.4.2 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (STAT3) .................... -15- 1.4.3 TRANSFORMING GROWTH FACTOR SS (TG FSS)......................................................- 20 - 2 AIMS............................................................................................................................. -23- 3 RESULTS.........................................................................................................................-24- 3.1 EFFICIENT GENE DELETION AND IMPAIRED PROTEIN ACTIVATION IN P38AMKO OR STAT3MKO MICE 3.2 SKIN INJURY AND ACUTE WOUND HEALING MOUSE MODEL -24- -26- 3.2.1 MYELOID CELL-RESTRICTED P38A DEFICIENCY HAS NO MAJOR IMPACT ON WOUND MORPHOLOGY AND KINETICS OF SKIN REPAIR..................................................................- 26 - 3.2.2 MYELOID CELL-RESTRICTED STAT3 DEFICIENCY HAS NO MAJOR IMPACT ON WOUND MORPHOLOGY AND KINETICS OF SKIN REPAIR..................................................................- 32 - 3.3 BLEOMYCIN-INDUCED SKIN FIBROSIS MOUSE MODEL.............................................- 36 - 3.3.1 MYELOID CELL-SPECIFIC STAT3 DEFICIENCY ACCELERATES THE DEVELOPMENT OF BLEOMYCIN-INDUCED SKIN FIBROSIS .............................................................................. - 36 - 3.3.2 MYELOID CELL-RESTRICTED STAT3 DEFICIENCY INCREASES COLLAGEN DEPOSITION IN BLEOMYCIN-INDUCED FIBROTIC LESIONS..........................................................................- 37 - 3.3.3 ENHANCED FIBROSIS IN STAT3MK0 MICE IS CHARACTERIZED BY INCREASED SMAD2 PHOSPHORYLATION AND COMP EXPRESSION ............................................................... -41 - 3.3.4 MYELOID CELL-SPECIFIC STAT3 DEFICIENCY LEADS TO AUGMENTED MAST CELL NUMBERS AT THE FIBROTIC EDGE OF THE BLEOMYCIN-INDUCED LESION ......................... - 42 - 3.3.5 STAT3-DEFICIENT MACROPHAGES FROM THE FIBROTIC LESION ARE DIFFERENTLY ACTIVATED AND EXPRESS LESS ANTI-FIBROTIC MEDIATORS .............................................. - 44 - 3.3.6 DECORIN EXPRESSION IS NOT REDUCED IN THE OVERALL FIBROTIC LESION OF STAT3MKO MICE IN VIVO.................................................................................................................- 45 - 3.3.7 IL-10 INCREASES SOCS3 EXPRESSION AND REPRESSES TGFSS PRODUCTION IN BMDMS VIA STAT3 SIGNALING IN VITRO.........................................................................- 46 - 3.3.6 IL-10 STIMULATED MACROPHAGES CONTROL THE EXPRESSION OF CTGF IN FIBROBLASTS IN VITRO....................................................................................................... - 49 - 4 DISCUSSION.................................................................................................................... -50- 4.1 P38AMKO MICE SHOW AN INCREASED NUMBER OF NEUTROPHILS IN THE EARLY WOUND TISSUE, YET SHOW NO MAJOR WOUND HEALING PHENOTYPE.............................................- 50 - 4.2 STAT3MKO MICE HAVE DIFFERENTLY ACTIVATED WOUND MACROPHAGES, YET SHOW NO MAJOR WOUND HEALING PHENOTYPE ................................................................................. - 51 - 4.3 MYELOID CELL-RESTRICTED STAT3 DEFICIENCY ACCELERATES THE DEVELOPMENT OF BLEOMYCIN-INDUCED SKIN FIBROSIS .................................................................................. - 52 - 4.3.1 STAT3 RESTRICTS THE AUTOCRINE TGFSS LOOP IN MACROPHAGES, THUS LIMITING TGFSS AVAILABILITY AND PRO-FIBROTIC FIBROBLAST ACTIVATION ....................................... - 52 - 4.3.2 IMPAIRED DECORIN EXPRESSION IN MACROPHAGES DOES NOT REDUCE THE TOTAL AMOUNT OF DECORIN IN BLEOMYCIN-INDUCED FIBROTIC SKIN ........................................ - 54 - 4.3.3 ACCELERATED FIBROSIS DEVELOPMENT IN STAT3MK0 MICE IS INDEPENDENT FROM PRO-INFLAMMATORY CYTOKINE EXPRESSION IN MACROPHAGES ................................... - 55 - 4.3.4 HOW MUCH DO ECM DEGRADATION AND PROTEOLYTIC ACTIVATION OF TGFSS CONTRIBUTE TO THE FIBROTIC PHENOTYPE?.....................................................................- 56 - 4.4 PERSPECTIVE...........................................................................................................-57- 5 MATERIALS AND METHODS.............................................................................................- 60 - 5.1 REAGENTS AND BUFFERS ........................................................................................ - 60 - 5.2 EXPERIMENTAL ANIMALS.........................................................................................- 61 - 5.2.1 MOUSE STRAINS (P38AMKO, STAT3MK0, TGFSSRIIMK0) ................................ -61 - 5.2.2 GENOTYPING................................................................................................... -61- 5.2.2.1 ISOLATION OF GENOMIC DMA.....................................................................- 61 - 5.2.2.2 P C R ......................................................................................................... -62- 5.2.3 WOUNDING..................................................................................................... -63- 5.2.3.1 FULL-THICKNESS SKIN EXCISIONAL WOUNDING...........................................- 63 - 5.2.3 2 BLEOMYCIN-INDUCED SKIN FIBROSIS......................................................... - 63 - 5.3 HISTOLOGY...............................................................................................................-64- 5.3.1 HISTOCHEMISTRY............................................................................................. -64- 5.3.2 I MM U NOHISTOCHEMISTRY................................................................................- 64 - 5.3.3 MORPHOMETRIC ANALYSIS................................................................................- 66 - 5.3.3.1 SIRIUS RED................................................................................................- 66 - 5.3.3.2 SECOND HARMONIC GENERATION MICROSCOPY ....................................... - 66 - 5.4 CELL ISOLATION FROM TISSUE................................................................................... - 67 - 5.4.1 FLUORESCENCE ACTIVATED CELL SORTING (FACS) ........................................... - 67 - 5.4.1 ISOLATION OF PRIMARY FIBROBLASTS..................................................................- 69 - 5.4.2 ISOLATION OF MACROPHAGES ( M 0 ) ................................................................- 69 - 5.4.2.1 PERITONEAL EXUDATE CELLS/ PERITONEAL MACROPHAGES ........................ - 69 - S.4.2.2 BONE-MARROW DERIVED MACROPHAGES (BM DM S) ............................. -6 9 5.5 CELL CULTURE...........................................................................................................- 70 5.5.1 CULTURE OF PRIMARY MACROPHAGES.............................................................-7 0 5.5.1 CULTURE OF PRIMARY FIBROBLASTS....................................................................- 71 5.5.2 TRANS-WELL CO-CULTURE OF MACROPHAGES AND FIBROBLASTS.......................-71 5.6 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) FOR TGFSS DETECTION ........ -7 2 5.7 RNA EXTRACTION, REVERSE TRANSCRIPTION PCR AND QRT-PCR........................- 72 5.8 WESTERN BLOT........................................................................................................ - 75 5.9 STATISTICAL ANALYSIS.............................................................................................. - 76 6 REFERENCES..................................................................................................................- 77 7 ABBREVIATIONS............................................................................................................. -8 6 6 ACKNOWLEDGEMENTS...................................................................................................- 90 9 EIDESSTATTLICHE ERKLAERUNG......................................................................................... - 91
any_adam_object	1
author	Do, Nhu-Nguyen
author_GND	(DE-588)1125143614
author_facet	Do, Nhu-Nguyen
author_role	aut
author_sort	Do, Nhu-Nguyen
author_variant	n n d nnd
building	Verbundindex
bvnumber	BV044465056
ctrlnum	(OCoLC)990781560 (DE-599)DNB1131738160
discipline	Medizin
format	Thesis Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01312nam a2200337 c 4500</leader><controlfield tag="001">BV044465056</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">170829s2017 gw a\|\|\| m\|\|\| 00\|\|\| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">17,H06</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1131738160</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)990781560</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1131738160</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-83</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Do, Nhu-Nguyen</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1125143614</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis</subfield><subfield code="c">vorgelegt von Nhu-Nguyen Do</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Köln</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">91 Seiten</subfield><subfield code="b">Illustrationen</subfield><subfield code="c">21 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Universität zu Köln</subfield><subfield code="d">2017</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://d-nb.info/1131738160/04</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029865631&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029865631</subfield></datafield></record></collection>
genre	(DE-588)4113937-9 Hochschulschrift gnd-content
genre_facet	Hochschulschrift
id	DE-604.BV044465056
illustrated	Illustrated
indexdate	2024-07-10T07:53:41Z
institution	BVB
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-029865631
oclc_num	990781560
open_access_boolean
owner	DE-83 DE-355 DE-BY-UBR
owner_facet	DE-83 DE-355 DE-BY-UBR
physical	91 Seiten Illustrationen 21 cm
publishDate	2017
publishDateSearch	2017
publishDateSort	2017
record_format	marc
spelling	Do, Nhu-Nguyen Verfasser (DE-588)1125143614 aut Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis vorgelegt von Nhu-Nguyen Do Köln 2017 91 Seiten Illustrationen 21 cm txt rdacontent n rdamedia nc rdacarrier Dissertation Universität zu Köln 2017 (DE-588)4113937-9 Hochschulschrift gnd-content B:DE-101 application/pdf http://d-nb.info/1131738160/04 Inhaltsverzeichnis DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029865631&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis
spellingShingle	Do, Nhu-Nguyen Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis
subject_GND	(DE-588)4113937-9
title	Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis
title_auth	Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis
title_exact_search	Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis
title_full	Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis vorgelegt von Nhu-Nguyen Do
title_fullStr	Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis vorgelegt von Nhu-Nguyen Do
title_full_unstemmed	Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis vorgelegt von Nhu-Nguyen Do
title_short	Functional consequences of myeloid cell-specific Stat3 activation in skin fibrosis
title_sort	functional consequences of myeloid cell specific stat3 activation in skin fibrosis
topic_facet	Hochschulschrift
url	http://d-nb.info/1131738160/04 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029865631&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv	AT donhunguyen functionalconsequencesofmyeloidcellspecificstat3activationinskinfibrosis

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Inhaltsverzeichnis
Inhaltsverzeichnis

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge